Health

Survival Benefit in Metastatic CRPC Study Spurs Questions on Patient Selection

TribeNews
By TribeNews Add a Comment
0 Min Read
Survival Benefit in Metastatic CRPC Study Spurs Questions on Patient Selection

MedPage Today) — In a recent MedPage Today video, Neeraj Agarwal, MD, of the Huntsman Cancer Institute at the University of Utah in Salt Lake City, reviewed the TALAPRO-2 trial’s implications for frontline treatment of metastatic castration-resistant…

Leave a Comment
Ads Blocker Image Powered by Code Help Pro

Ads Blocker Detected & This Is Prohibited!!!

We have detected that you are using extensions to block ads and you are also not using our official app. Your Account Have been Flagged and reported, pending de-activation & All your earning will be wiped out. Please turn off the software to continue

You cannot copy content of this app